Table 4 Patient-reported outcome measures relative to chemoprophylaxis use
Patients given chemoprophylaxis (median) | Patients not given chemoprophylaxis (median) | p value | ||
|---|---|---|---|---|
Pre-op | SF36v2 PCS | 30.45 | 30.09 | 0.312 |
SF36v2 MCS | 58.68 | 58.60 | 0.171 | |
WOMAC | 67.20 | 65.20 | 0.222 | |
KSS Function | 50.00 | 50.00 | 0.249 | |
KSS Knee | 41.50 | 36.00 | 0.054 | |
Post-op 6 months | SF36v2 PCS | 48.53 | 47.94 | 0.857 |
SF36v2 MCS | 58.60 | 58.50 | 0.403 | |
WOMAC | 91.70 | 90.63 | 0.537 | |
KSS Function | 80.00 | 70.00 | 0.325 | |
KSS Knee | 94.00 | 94.00 | 0.687 | |
Post-op 24 months | SF36v2 PCS | 48.00 | 49.37 | 0.391 |
SF36v2 MCS | 59.00 | 58.83 | 0.352 | |
WOMAC | 90.91 | 92.97 | 0.218 | |
KSS Function | 80.00 | 80.00 | 0.189 | |
KSS Knee | 95.00 | 97.00 | 0.979 |